Progenitor Cell Mobilizing Treatments Prevent Experimental Transplant Arteriosclerosis - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Journal of Surgical Research Year : 2012

Progenitor Cell Mobilizing Treatments Prevent Experimental Transplant Arteriosclerosis

Domains

Cardiology and cardiovascular system Tissues and Organs [q-bio.TO] Biotechnology Immunology Pharmaceutical sciences
Embargoed file
Embargoed file
Ne sera jamais visible

Ebba Brakenhielm  : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-02296572

Submitted on : Wednesday, September 25, 2019-12:10:30 PM

Last modification on : Wednesday, March 2, 2022-9:40:13 AM

Long-term archiving on: Sunday, February 9, 2020-5:36:54 PM

Embargoed file
Please log in to request access to the document

Dates and versions

inserm-02296572 , version 1 (25-09-2019)

Identifiers

Cite

Nicolas Roux, Ebba Brakenhielm, Caroline Freguin-Bouillant, Françoise Lallemand, Jean-Paul Henry, et al.. Progenitor Cell Mobilizing Treatments Prevent Experimental Transplant Arteriosclerosis. Journal of Surgical Research, 2012, 176 (2), pp.657-665. ⟨10.1016/j.jss.2011.11.1014⟩. ⟨inserm-02296572⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM COMUE-NORMANDIE UNIROUEN U1234PANTHER
21 View
1 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More